Last updated at 21 Jun 2024 04:41 AM
Director
DIN: 00356525
Sudhir Mohanlal Sankalecha is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at NASIK ADVANCED PATHOLOGY LABORATORY PRIV ATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00356525.Sudhir Mohanlal Sankalecha is currently involved in 2 different roles. Their most recent position is with SALIL HOTELS LLP as a Designated Partner. The first company Sudhir Mohanlal Sankalecha was appointed to as a director was NASIK ADVANCED PATHOLOGY LABORATORY PRIV ATE LIMITED. Sudhir Mohanlal Sankalecha is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sudhir Mohanlal Sankalecha is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at NASIK ADVANCED PATHOLOGY LABORATORY PRIV ATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00356525.Sudhir Mohanlal Sankalecha is currently involved in 2 different roles. Their most recent position is with SALIL HOTELS LLP as a Designated Partner. The first company Sudhir Mohanlal Sankalecha was appointed to as a director was NASIK ADVANCED PATHOLOGY LABORATORY PRIV ATE LIMITED. Sudhir Mohanlal Sankalecha is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (0)
5y 10m 2y 11m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| NASIK ADVANCED PATHOLOGY LABORATORY PRIV ATE LIMITED | Director | 26-Feb-1997 |
| SALIL HOTELS PRIVATE LIMITED | Director | 02-Dec-2008 |